Available in the shop
- MOTS-c 10 mg — $109.20
- MOTS-c 20 mg — $218.40
- MOTS-c 40 mg — $436.80
Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.
Identification
| Field of research | Anti-ageing research |
|---|---|
| Formula | C101H152N28O22S2 |
| Molecular weight | 2174.6 g/mol |
| CAS number | 1627580-64-6 |
| Also known as | MOTS-c (human) (trifluoroacetate salt), A5CV6JFB78, H-MRWQEMGYIFYPRKLR-OH, orb2279120, orb3032863, Mitochondria-derived peptide mots-c, EX-A6267, PP51038, DA-65618, T77782 |
| PubChem | CID 146675088 |
Summary
MOTS-c is a 16-amino-acid peptide that in humans is encoded by the mitochondrial MT-RNR1 gene, with the amino acid sequence MRWQEMGYIFYPRKLR. It is believed to be involved in regulating metabolism of glucose by skeletal muscle tissue.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitationReviewResearch Support, Non-U.S. Gov'tZheng Y, Wei Z, Wang T · Front Endocrinol (Lausanne), 2023 · PMID 36761202 · DOI
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tLee C, Zeng J, Drew BG et al. · Cell Metab, 2015 · PMID 25738459 · DOI
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 DeubiquitinationResearch Support, Non-U.S. Gov'tYin Y, Li Y, Ma B et al. · Adv Sci (Weinh), 2024 · PMID 39321430 · DOI
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasisResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tReynolds JC, Lai RW, Woodhead JST et al. · Nat Commun, 2021 · PMID 33473109 · DOI
- The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitusResearch Support, Non-U.S. Gov'tYin Y, Pan Y, He J et al. · Pharmacol Res, 2022 · PMID 34798268 · DOI
- MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genesResearch Support, Non-U.S. Gov'tLi X, Zhan F, Qiu G et al. · Redox Biol, 2025 · PMID 40403491 · DOI
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
- Circulating levels of MOTS-c in patients with breast cancer treated with metforminRandomized Controlled TrialResearch Support, Non-U.S. Gov'tCuyàs E, Verdura S, Martin-Castillo B et al. · Aging (Albany NY), 2022 · PMID 36490309 · DOI
Top 8 of 257 results, by relevance. See all on PubMed.
Search query "MOTS-c"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 146675088 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | MOTS-c |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.